 Kristen Boyle
Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 22 | 2025 | 3149 | 2.470 |
Why?
| | Adiposity | 11 | 2026 | 533 | 2.100 |
Why?
| | Fatty Acids | 7 | 2024 | 461 | 1.650 |
Why?
| | Pediatric Obesity | 7 | 2025 | 640 | 1.580 |
Why?
| | Lipid Metabolism | 10 | 2024 | 538 | 1.300 |
Why?
| | Umbilical Cord | 4 | 2025 | 93 | 1.190 |
Why?
| | DNA Methylation | 5 | 2023 | 722 | 1.100 |
Why?
| | Muscle, Skeletal | 8 | 2017 | 1798 | 0.960 |
Why?
| | Pregnancy | 23 | 2026 | 7274 | 0.930 |
Why?
| | Prenatal Exposure Delayed Effects | 5 | 2025 | 663 | 0.890 |
Why?
| | Circadian Clocks | 1 | 2023 | 59 | 0.770 |
Why?
| | Adipogenesis | 3 | 2023 | 56 | 0.750 |
Why?
| | Infant, Newborn | 13 | 2025 | 6543 | 0.750 |
Why?
| | Pregnancy Complications | 2 | 2021 | 606 | 0.750 |
Why?
| | Mitochondrial Proteins | 3 | 2014 | 264 | 0.720 |
Why?
| | AMP-Activated Protein Kinases | 4 | 2024 | 192 | 0.720 |
Why?
| | Diet, High-Fat | 3 | 2025 | 267 | 0.620 |
Why?
| | Mothers | 3 | 2025 | 774 | 0.610 |
Why?
| | Diabetes, Gestational | 2 | 2014 | 307 | 0.610 |
Why?
| | Fatty Acid Desaturases | 1 | 2020 | 32 | 0.610 |
Why?
| | Transgenes | 1 | 2020 | 190 | 0.580 |
Why?
| | Mitochondria | 7 | 2022 | 1000 | 0.580 |
Why?
| | Spectrophotometry | 1 | 2019 | 58 | 0.570 |
Why?
| | Electron Transport Complex I | 1 | 2019 | 42 | 0.560 |
Why?
| | Enzymes | 1 | 2019 | 60 | 0.550 |
Why?
| | Maternal Exposure | 1 | 2020 | 190 | 0.540 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2020 | 209 | 0.520 |
Why?
| | Oxidation-Reduction | 9 | 2021 | 1077 | 0.520 |
Why?
| | Placenta | 5 | 2026 | 793 | 0.490 |
Why?
| | Oxidative Stress | 3 | 2020 | 1368 | 0.480 |
Why?
| | Birth Weight | 4 | 2024 | 522 | 0.480 |
Why?
| | Fenofibrate | 1 | 2016 | 28 | 0.480 |
Why?
| | PPAR gamma | 2 | 2016 | 182 | 0.450 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 83 | 0.450 |
Why?
| | Insulin | 9 | 2026 | 2526 | 0.450 |
Why?
| | Infant | 12 | 2025 | 10194 | 0.430 |
Why?
| | Female | 32 | 2026 | 80076 | 0.430 |
Why?
| | Dietary Fats | 3 | 2010 | 309 | 0.410 |
Why?
| | Allostasis | 2 | 2025 | 17 | 0.400 |
Why?
| | Muscle Development | 3 | 2021 | 113 | 0.390 |
Why?
| | Electron Transport Complex II | 1 | 2013 | 27 | 0.390 |
Why?
| | beta Catenin | 1 | 2015 | 254 | 0.390 |
Why?
| | Sirtuin 3 | 1 | 2013 | 60 | 0.370 |
Why?
| | Muscle Proteins | 1 | 2014 | 244 | 0.370 |
Why?
| | Calcium Signaling | 1 | 2014 | 246 | 0.360 |
Why?
| | Triglycerides | 4 | 2024 | 529 | 0.360 |
Why?
| | DNA, Mitochondrial | 2 | 2022 | 212 | 0.350 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2011 | 212 | 0.340 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 308 | 0.340 |
Why?
| | Lipid Peroxidation | 1 | 2011 | 169 | 0.330 |
Why?
| | Glucose | 3 | 2023 | 1051 | 0.330 |
Why?
| | Humans | 41 | 2026 | 147293 | 0.330 |
Why?
| | Fluorocarbons | 2 | 2023 | 122 | 0.320 |
Why?
| | Environmental Pollutants | 2 | 2023 | 142 | 0.320 |
Why?
| | Precision Medicine | 2 | 2025 | 464 | 0.310 |
Why?
| | Electron Transport | 4 | 2019 | 110 | 0.290 |
Why?
| | Body Mass Index | 8 | 2025 | 2470 | 0.270 |
Why?
| | Child, Preschool | 10 | 2026 | 12016 | 0.250 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2022 | 154 | 0.250 |
Why?
| | TOR Serine-Threonine Kinases | 3 | 2026 | 456 | 0.250 |
Why?
| | Epigenesis, Genetic | 3 | 2025 | 708 | 0.230 |
Why?
| | Insulin, Regular, Human | 2 | 2022 | 47 | 0.230 |
Why?
| | Cells, Cultured | 4 | 2025 | 4169 | 0.220 |
Why?
| | Epigenomics | 1 | 2025 | 125 | 0.220 |
Why?
| | Male | 22 | 2026 | 73950 | 0.210 |
Why?
| | Adult | 16 | 2026 | 41405 | 0.210 |
Why?
| | Fetal Blood | 2 | 2023 | 327 | 0.200 |
Why?
| | Child | 9 | 2025 | 22979 | 0.200 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 17 | 0.200 |
Why?
| | Caprylates | 1 | 2023 | 21 | 0.200 |
Why?
| | Hypertrophy | 1 | 2023 | 128 | 0.190 |
Why?
| | Disease Susceptibility | 1 | 2025 | 347 | 0.190 |
Why?
| | Cannabidiol | 1 | 2024 | 142 | 0.180 |
Why?
| | Inflammation | 3 | 2026 | 2920 | 0.180 |
Why?
| | Cell Differentiation | 2 | 2023 | 2054 | 0.180 |
Why?
| | Obesity, Metabolically Benign | 1 | 2021 | 4 | 0.180 |
Why?
| | Pregnancy Proteins | 1 | 2022 | 36 | 0.170 |
Why?
| | Dronabinol | 1 | 2024 | 251 | 0.170 |
Why?
| | Adipocytes | 1 | 2023 | 223 | 0.170 |
Why?
| | Fetal Development | 1 | 2025 | 298 | 0.170 |
Why?
| | Metabolic Flux Analysis | 1 | 2021 | 8 | 0.170 |
Why?
| | Signal Transduction | 3 | 2026 | 5272 | 0.170 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 10 | 0.170 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 17 | 0.160 |
Why?
| | Fasting | 1 | 2023 | 280 | 0.160 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 39 | 0.160 |
Why?
| | Metabolic Networks and Pathways | 1 | 2021 | 175 | 0.160 |
Why?
| | Myocardium | 1 | 2025 | 947 | 0.150 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2017 | 49 | 0.150 |
Why?
| | Fibroblasts | 1 | 2025 | 1039 | 0.150 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 264 | 0.150 |
Why?
| | Premature Birth | 1 | 2023 | 390 | 0.150 |
Why?
| | Aconitate Hydratase | 1 | 2019 | 14 | 0.140 |
Why?
| | Gene Expression | 1 | 2023 | 1481 | 0.140 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2021 | 318 | 0.140 |
Why?
| | Young Adult | 6 | 2017 | 14437 | 0.140 |
Why?
| | Carnitine | 3 | 2017 | 91 | 0.140 |
Why?
| | Phosphorylation | 3 | 2021 | 1721 | 0.140 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 425 | 0.130 |
Why?
| | Pilot Projects | 1 | 2023 | 1912 | 0.130 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 32 | 0.130 |
Why?
| | Metabolic Syndrome | 1 | 2021 | 365 | 0.130 |
Why?
| | Animals | 6 | 2023 | 38410 | 0.130 |
Why?
| | Insulin Resistance | 4 | 2025 | 1253 | 0.130 |
Why?
| | Caenorhabditis elegans | 1 | 2020 | 330 | 0.120 |
Why?
| | Mice, Transgenic | 2 | 2020 | 2197 | 0.120 |
Why?
| | Environmental Exposure | 1 | 2020 | 583 | 0.120 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 74 | 0.110 |
Why?
| | Niacinamide | 1 | 2016 | 104 | 0.110 |
Why?
| | Glucose Tolerance Test | 2 | 2014 | 361 | 0.110 |
Why?
| | Transcription Factors | 1 | 2023 | 1747 | 0.110 |
Why?
| | Amino Acids | 2 | 2017 | 519 | 0.110 |
Why?
| | Longitudinal Studies | 3 | 2020 | 3027 | 0.110 |
Why?
| | Adenylate Kinase | 1 | 2014 | 26 | 0.110 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 1107 | 0.110 |
Why?
| | Exercise Tolerance | 1 | 2017 | 289 | 0.110 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2015 | 165 | 0.100 |
Why?
| | Glutathione | 2 | 2013 | 370 | 0.100 |
Why?
| | Metabolome | 1 | 2017 | 391 | 0.100 |
Why?
| | Prediabetic State | 1 | 2016 | 251 | 0.100 |
Why?
| | Interleukin-1 | 1 | 2017 | 961 | 0.090 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 915 | 0.090 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 2218 | 0.080 |
Why?
| | Uncoupling Protein 3 | 1 | 2010 | 9 | 0.080 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2010 | 10 | 0.080 |
Why?
| | Membrane Proteins | 1 | 2017 | 1171 | 0.080 |
Why?
| | PPAR alpha | 1 | 2010 | 56 | 0.080 |
Why?
| | Lipolysis | 1 | 2010 | 44 | 0.080 |
Why?
| | Ion Channels | 1 | 2010 | 129 | 0.080 |
Why?
| | Subcutaneous Fat | 1 | 2010 | 79 | 0.080 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 176 | 0.080 |
Why?
| | Metabolomics | 1 | 2015 | 736 | 0.070 |
Why?
| | Diet | 2 | 2022 | 1284 | 0.070 |
Why?
| | Rodentia | 1 | 2009 | 62 | 0.070 |
Why?
| | Myostatin | 1 | 2008 | 24 | 0.070 |
Why?
| | Energy Metabolism | 3 | 2022 | 936 | 0.070 |
Why?
| | Mice | 4 | 2020 | 18491 | 0.070 |
Why?
| | Prostatic Neoplasms | 1 | 2015 | 986 | 0.070 |
Why?
| | Proteomics | 1 | 2014 | 1203 | 0.060 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 338 | 0.060 |
Why?
| | Adolescent | 5 | 2016 | 22825 | 0.060 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2625 | 0.060 |
Why?
| | Bioprinting | 1 | 2025 | 34 | 0.050 |
Why?
| | Cohort Studies | 1 | 2015 | 6099 | 0.050 |
Why?
| | Cell Proliferation | 1 | 2011 | 2529 | 0.050 |
Why?
| | Obesity, Morbid | 1 | 2008 | 298 | 0.050 |
Why?
| | Blood Glucose | 2 | 2010 | 2359 | 0.050 |
Why?
| | Exercise | 2 | 2022 | 2219 | 0.050 |
Why?
| | Hydrocortisone | 1 | 2025 | 300 | 0.050 |
Why?
| | RNA, Messenger | 1 | 2010 | 2812 | 0.050 |
Why?
| | Biomechanical Phenomena | 1 | 2025 | 873 | 0.040 |
Why?
| | Weight Loss | 1 | 2008 | 867 | 0.040 |
Why?
| | Prospective Studies | 2 | 2025 | 8164 | 0.040 |
Why?
| | Bayes Theorem | 1 | 2023 | 428 | 0.040 |
Why?
| | Extracellular Matrix | 1 | 2025 | 566 | 0.040 |
Why?
| | Breast Feeding | 1 | 2024 | 447 | 0.040 |
Why?
| | Biomarkers | 3 | 2020 | 4351 | 0.040 |
Why?
| | Skinfold Thickness | 1 | 2020 | 43 | 0.040 |
Why?
| | Gestational Age | 1 | 2023 | 997 | 0.040 |
Why?
| | Child Development | 1 | 2024 | 484 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 742 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 590 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 121 | 0.040 |
Why?
| | Risk Factors | 2 | 2025 | 11017 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1049 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4591 | 0.030 |
Why?
| | Sex Characteristics | 1 | 2023 | 799 | 0.030 |
Why?
| | Stem Cells | 1 | 2022 | 630 | 0.030 |
Why?
| | Muscle Cells | 1 | 2017 | 41 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 15 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 105 | 0.030 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 94 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 83 | 0.030 |
Why?
| | Stress, Psychological | 1 | 2025 | 1174 | 0.030 |
Why?
| | Sirtuin 1 | 1 | 2016 | 35 | 0.030 |
Why?
| | Aged | 2 | 2016 | 26514 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 104 | 0.030 |
Why?
| | Middle Aged | 3 | 2016 | 36821 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 211 | 0.030 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2017 | 178 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2017 | 212 | 0.030 |
Why?
| | Epoxy Compounds | 1 | 2015 | 31 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 143 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2017 | 242 | 0.030 |
Why?
| | Postprandial Period | 1 | 2015 | 115 | 0.030 |
Why?
| | Running | 1 | 2017 | 234 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 849 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 636 | 0.020 |
Why?
| | Mice, Nude | 1 | 2015 | 680 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1371 | 0.020 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 344 | 0.020 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 863 | 0.020 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 1046 | 0.020 |
Why?
| | Lipids | 1 | 2017 | 723 | 0.020 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 6041 | 0.020 |
Why?
| | Cell Line | 1 | 2017 | 2832 | 0.020 |
Why?
| | Cholesterol | 2 | 2010 | 410 | 0.020 |
Why?
| | Microdialysis | 1 | 2010 | 56 | 0.020 |
Why?
| | Glycerol | 1 | 2010 | 90 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2010 | 202 | 0.020 |
Why?
| | Glutathione Disulfide | 1 | 2009 | 30 | 0.020 |
Why?
| | Adenosine Diphosphate | 1 | 2009 | 83 | 0.020 |
Why?
| | Catalase | 1 | 2009 | 134 | 0.020 |
Why?
| | Glucose Clamp Technique | 1 | 2009 | 199 | 0.020 |
Why?
| | Immunoblotting | 1 | 2008 | 296 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 3565 | 0.020 |
Why?
| | Oligopeptides | 1 | 2009 | 267 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2008 | 453 | 0.020 |
Why?
| | Hypolipoproteinemias | 1 | 1986 | 2 | 0.010 |
Why?
| | Hyperlipoproteinemias | 1 | 1986 | 5 | 0.010 |
Why?
| | Gastric Bypass | 1 | 2008 | 126 | 0.010 |
Why?
| | Oxygen Consumption | 1 | 2009 | 721 | 0.010 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1415 | 0.010 |
Why?
| | Tandem Mass Spectrometry | 1 | 2008 | 575 | 0.010 |
Why?
| | Antioxidants | 1 | 2009 | 550 | 0.010 |
Why?
| | Body Weight | 1 | 2008 | 976 | 0.010 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2542 | 0.010 |
Why?
| | Rats | 1 | 2009 | 5613 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 6011 | 0.010 |
Why?
| | Xanthomatosis | 1 | 1986 | 8 | 0.000 |
Why?
| | Nutritional Physiological Phenomena | 1 | 1986 | 57 | 0.000 |
Why?
| | Lipoproteins, HDL | 1 | 1986 | 104 | 0.000 |
Why?
| | Arterial Occlusive Diseases | 1 | 1986 | 90 | 0.000 |
Why?
| | Physical Exertion | 1 | 1986 | 205 | 0.000 |
Why?
| | Electrocardiography | 1 | 1986 | 675 | 0.000 |
Why?
| | Heart Rate | 1 | 1986 | 860 | 0.000 |
Why?
| | Blood Pressure | 1 | 1986 | 1785 | 0.000 |
Why?
|
|
Boyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|